University of Patras
Η επίδραση της αντισυλληπτικής αγωγής στους γενετικούς, αγγειακούς, βιοχημικούς και ορμονικούς πρώιμους δείκτες αυξημένου κινδύνου σε νέες γυναίκες με σύνδρομο πολυκυστικών ωοθηκών (PCOS)
Abstract
dc:descriptionObjectives: To investigate the influence of 6 months of treatment with an oral contraceptive (OC) containing 35μg ethinyl estradiol and 2mg cyproterone acetate on plasma viscosity in young women with PCOS. Design: PCOS patients were assessed for plasma viscosity before and after 6 months of treatment with an OC containing 35μg ethinyl estradiol and 2mg cyproterone acetate. Plasma viscosity was determined by a viscometer Type 53610/I SCHOTT-Instruments, Mainz at 37o C. Settings: Subjects were recruited from the Department of Obstetrics and Gynaecology, Division of Reproductive Endocrinology at the University Hospital of Patras, Greece. Patients: The study included 66 young PCOS women. Main Outcome measures: Plasma viscosity. Results: In PCOS women as a whole, plasma viscosity at baseline was 1.249±0.049 mm²/s (n=66). After 6 months of treatment with an oral contraceptive containing 35μg ethinyl estradiol and 2mg cyproterone acetate, plasma viscosity increased to 1.268±0.065 mm²/s (p=0.038). The difference between plasma viscosity before and after 6 months of treatment with an oral contraceptive containing 35μg ethinyl estradiol and 2mg cyproterone acetate (Δviscosity) was 0,01864±,071452 mm²/s. Δviscosity was related to Δfibrinogen (r=0.270, p=0.046), to Δ haematocrit (r=0.514, p=0.09) and to Δ triglycerides (r=0.292, p=0.021). Conclusion: Young PCOS women presented an increased plasma viscosity under OC treatment, which therefore should be used with caution.
Degree
thesis:*- Grantor dc:publisher
- University of Patras
- Year dc:date
- 2013
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Markantes, Georgios
- Μαρκαντές, Γεώργιος
Subjects
dc:subject × 18- Σύνδρομο πολυκυστικών ωοθηκών
- Υπερανδρογοναιμία
- Αντίσταση στην ινσουλίνη
- Γλοιότητα πλάσματος
- Αντισυλληπτικά δίσκια
- Αιθινυλ-οιστραδιόλη
- Οξική κυπροτερόνη
- Polycystic ovary syndrome (PCOS)
- Hyperandrogenemia
- Insulin resistance
- Plasma viscosity
- Oral contraceptives
- Ethinyl estrabiol
- Cyproterone acetate
- Ιατρική και Επιστήμες Υγείας
- Κλινική Ιατρική
- Medical and Health Sciences
- Clinical Medicine
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/36878